Ketoconazole: Difference between revisions
| Line 19: | Line 19: | ||
*[[Lactation risk categories|Lactation risk]]: | *[[Lactation risk categories|Lactation risk]]: | ||
===Renal Dosing=== | ===Renal Dosing=== | ||
*Adult: | *Adult: no adjustment | ||
*Pediatric: | *Pediatric: no adjustment | ||
===Hepatic Dosing=== | ===Hepatic Dosing=== | ||
*Adult: | *Adult: | ||
Revision as of 01:12, 17 September 2015
Administration
- Type: Antifungal
- Dosage Forms:
- Routes of Administration: PO, topical
- Common Trade Names:
Adult Dosing
- Fungal infxns
- 200-400 mg PO qday
- Prostate cancer
- 400 mg PO q8h
Pediatric Dosing
- Fungal infxns (2 years and up)
- 3.3-6.6 mg/kg PO qday
Special Populations
Renal Dosing
- Adult: no adjustment
- Pediatric: no adjustment
Hepatic Dosing
- Adult:
- Pediatric:
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion: